ROCKVILLE, Md. (AP) — ROCKVILLE, Md. (AP) — Regenxbio Inc. (RGNX) on Wednesday reported a loss of $63.3 million in its first quarter.

The Rockville, Maryland-based company said it had a loss of $1.38 per share.

The results fell short of Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of $1.28 per share.

The biotechnology company posted revenue of $15.6 million in the period, also missing Street forecasts. Five analysts surveyed by Zacks expected $25.1 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RGNX at https://www.zacks.com/ap/RGNX

For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights. , source Associated Press News